GlassScriptPhysician profile
Rakesh V Gupta
NPI 1972554020
$8,946.75
in general payments reported to CMS, 2019-2025
34 companies · $4,267 in 2025
The $4,267 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,159 · 2020: $518 · 2021: $768 · 2022: $942 · 2023: $642 · 2024: $651 · 2025: $4,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,264 · Food and Beverage: $2,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,263.52 |
| Food and Beverage | $2,296.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $3,991.27 | 2025 | |
| Abbott Laboratories | $1,003.72 | 2019-2023 | Jot Dx |
| Novartis Pharmaceuticals Corporation | $618.48 | 2019-2025 | |
| Atricure, INC. | $554.53 | 2021-2023 | |
| Shockwave Medical, INC | $474.97 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $418.76 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $305.35 | 2019-2025 | Avvigo Guidance System, Watchman Flx |
| Cordis US Corp. | $201.64 | 2021-2023 | Mynx Control, Saber |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.21 | 2019-2024 | Lifevest |
| Medtronic Vascular, INC. | $175.39 | 2019 | |
| Pfizer INC. | $134.69 | 2019-2025 | |
| Novo Nordisk INC | $109.26 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| E.R. Squibb & Sons, L.L.C. | $88.17 | 2023-2024 | Camzyos, Eliquis |
| Baxter Healthcare | $67.82 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $63.99 | 2020-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $58.43 | 2022-2024 | Verquvo |
| Kowa Pharmaceuticals America, INC. | $54.51 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.35 | 2022-2024 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $44.94 | 2023 | Opsumit, Uptravi |
| Amarin Pharma, INC. | $42.72 | 2019 | |
| Gilead Sciences, INC. | $42.17 | 2019 | |
| Amgen INC. | $39.92 | 2019-2024 | Repatha |
| Scpharmaceuticals INC. | $34.62 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $30.07 | 2019 | |
| Medtronic, INC. | $22.90 | 2021 | |
| Cvrx, INC. | $19.88 | 2024 | Barostim Neo System |
| Edwards Lifesciences Corporation | $16.54 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kestra Medical Technology Services, INC. | $16.26 | 2024 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $14.52 | 2023 | Inpefa |
| Astellas Pharma US INC | $13.92 | 2019 | |
| Alnylam Pharmaceuticals INC. | $13.44 | 2024 | Amvuttra |
| Terumo Medical Corporation | $11.34 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 | |
| Cardiovascular Systems INC. | $6.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakesh Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.